| Product Code: ETC8839064 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The Philippines saw a steady increase in cyclosporine import shipments in 2024, with key exporting countries such as India, Germany, USA, Metropolitan France, and Italy leading the way. Despite the growth, market concentration, as measured by the Herfindahl-Hirschman Index (HHI), remained low, indicating a competitive market environment. The compound annual growth rate (CAGR) from 2020 to 2024 stood at a healthy 7.01%, with a slight uptick in growth rate from 2023 to 2024 at 0.9%. This data suggests a positive trajectory for the cyclosporine market in the Philippines.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Philippines Cyclosporine Market Overview |
3.1 Philippines Country Macro Economic Indicators |
3.2 Philippines Cyclosporine Market Revenues & Volume, 2021 & 2031F |
3.3 Philippines Cyclosporine Market - Industry Life Cycle |
3.4 Philippines Cyclosporine Market - Porter's Five Forces |
3.5 Philippines Cyclosporine Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.6 Philippines Cyclosporine Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 Philippines Cyclosporine Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.8 Philippines Cyclosporine Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Philippines Cyclosporine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of autoimmune diseases in the Philippines |
4.2.2 Growing awareness and acceptance of cyclosporine treatment among healthcare professionals and patients |
4.2.3 Rising healthcare expenditure and government initiatives to improve access to specialty medications |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval and distribution of cyclosporine products |
4.3.2 Competition from alternative treatments and generic drugs in the market |
4.3.3 Potential side effects and safety concerns associated with cyclosporine usage |
5 Philippines Cyclosporine Market Trends |
6 Philippines Cyclosporine Market, By Types |
6.1 Philippines Cyclosporine Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 Philippines Cyclosporine Market Revenues & Volume, By Indication, 2021- 2031F |
6.1.3 Philippines Cyclosporine Market Revenues & Volume, By Transplant Rejection Prophylaxis, 2021- 2031F |
6.1.4 Philippines Cyclosporine Market Revenues & Volume, By Rheumatoid Arthritis, 2021- 2031F |
6.1.5 Philippines Cyclosporine Market Revenues & Volume, By Psoriasis, 2021- 2031F |
6.1.6 Philippines Cyclosporine Market Revenues & Volume, By Autoimmune Myasthenia Gravis, 2021- 2031F |
6.1.7 Philippines Cyclosporine Market Revenues & Volume, By Dry Eye, 2021- 2031F |
6.1.8 Philippines Cyclosporine Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Philippines Cyclosporine Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 Philippines Cyclosporine Market Revenues & Volume, By Oral, 2021- 2031F |
6.2.3 Philippines Cyclosporine Market Revenues & Volume, By Injectable, 2021- 2031F |
6.2.4 Philippines Cyclosporine Market Revenues & Volume, By Topical, 2021- 2031F |
6.3 Philippines Cyclosporine Market, By End-Users |
6.3.1 Overview and Analysis |
6.3.2 Philippines Cyclosporine Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 Philippines Cyclosporine Market Revenues & Volume, By Homecare, 2021- 2031F |
6.3.4 Philippines Cyclosporine Market Revenues & Volume, By Speciality Centres, 2021- 2031F |
6.3.5 Philippines Cyclosporine Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Philippines Cyclosporine Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Philippines Cyclosporine Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.4.3 Philippines Cyclosporine Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.4.4 Philippines Cyclosporine Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
7 Philippines Cyclosporine Market Import-Export Trade Statistics |
7.1 Philippines Cyclosporine Market Export to Major Countries |
7.2 Philippines Cyclosporine Market Imports from Major Countries |
8 Philippines Cyclosporine Market Key Performance Indicators |
8.1 Patient adherence rate to cyclosporine treatment |
8.2 Number of new product launches or formulations in the cyclosporine market |
8.3 Rate of prescription of cyclosporine by healthcare providers |
8.4 Average time to market for cyclosporine products |
8.5 Percentage of patients achieving desired therapeutic outcomes |
9 Philippines Cyclosporine Market - Opportunity Assessment |
9.1 Philippines Cyclosporine Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.2 Philippines Cyclosporine Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 Philippines Cyclosporine Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.4 Philippines Cyclosporine Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Philippines Cyclosporine Market - Competitive Landscape |
10.1 Philippines Cyclosporine Market Revenue Share, By Companies, 2024 |
10.2 Philippines Cyclosporine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |